Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Michelle Dian Reid

Matched on ORCID iD 0000-0002-3812-4098; OpenAlex author ID A5001840708. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers

Papers 8

  1. "Simple Mucinous Cysts" associated with pancreatic ductal adenocarcinoma: clinicopathologic and radiologic characterization of an enigmatic cyst and additional… Co-author DOI 10.1007/s00428-026-04705-w↗
  2. "Horses out of the barn": pancreatic ductal adenocarcinoma frequently extends beyond the grossly visible tumour, requiring microscopic rectification for accura… Co-author DOI 10.1111/his.70099↗
  3. Survival and Prognostic Factors in Patients With Pancreatic Colloid Carcinoma Compared With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000002227↗
  4. Pathologic Examination of Pancreatic Specimens Resected for Treated Pancreatic Ductal Adenocarcinoma: Recommendations From the Pancreatobiliary Pathology Socie… Co-author DOI 10.1097/pas.0000000000001853↗
  5. Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Editio… Co-author DOI 10.1245/s10434-016-5093-7↗
  6. Amplified centrosomes may underlie aggressive disease course in pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/15384101.2015.1068478↗
  7. Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Proposal for a Revised N Classification for TN… Co-author DOI 10.1245/s10434-015-4861-0↗
  8. Histopathologic assessment of pancreatic cancer: does one size fit all? Co-author DOI 10.1002/jso.23194↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Volkan N. Adsay · 6 shared papers, 2013–2026 · strength 0.76
  2. Olca Baştürk · 5 shared papers, 2015–2026 · strength 0.70
  3. Pelin Bağcı · 5 shared papers, 2013–2026 · strength 0.64
  4. Burcu Saka · 4 shared papers, 2015–2026 · strength 0.57
  5. Bassel F. El‐Rayes · 4 shared papers, 2015–2026 · strength 0.50
  6. Alyssa M. Krasinskas · 4 shared papers, 2015–2026 · strength 0.45
  7. David A. Kooby · 3 shared papers, 2015–2026 · strength 0.33
  8. Juan Manuel Sarmiento · 3 shared papers, 2015–2026 · strength 0.33
  9. Shishir Kumar Maithel · 3 shared papers, 2015–2026 · strength 0.33
  10. Cisel A. Mericoz · 1 shared paper, 2026 · strength 0.24
  11. Nuray Tezcan · 1 shared paper, 2026 · strength 0.24
  12. Christina Sing-Ying Wu · 1 shared paper, 2023 · strength 0.17
  13. Lana E. Khalil · 1 shared paper, 2023 · strength 0.17
  14. Olatunji Boladale Alese · 1 shared paper, 2023 · strength 0.17
  15. Walid Labib Shaib · 1 shared paper, 2023 · strength 0.17
  16. Mehmet Akce · 1 shared paper, 2023 · strength 0.17
  17. Deepti Dhall · 1 shared paper, 2022 · strength 0.12
  18. Kee‐Taek Jang · 1 shared paper, 2022 · strength 0.12
  19. Daniela S. Allende · 1 shared paper, 2022 · strength 0.12
  20. Huamin Wang · 1 shared paper, 2022 · strength 0.12
  21. Runjan Chetty · 1 shared paper, 2022 · strength 0.12
  22. Yoko Matsuda · 1 shared paper, 2022 · strength 0.12
  23. Rondell Patrell Graham · 1 shared paper, 2022 · strength 0.12
  24. Vikram Deshpande · 1 shared paper, 2022 · strength 0.12
  25. Grace Kim · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.